Analysis of Epstein–Barr virus infection in oral potentially malignant disorders and oral cancer: A cross-sectional study

Abstract The primary objective of this study is to determine the prevalence of Epstein–Barr virus (EBV) in oral potentially malignant disorders (OPMDs) and oral cancer (OC) in a group of Thais using polymerase chain reaction (PCR) and Epstein–Barr encoding regions (EBERs) in situ hybridization (ISH). The secondary objective is to investigate the risk factors of OC and the association between the presence of EBV and risk factors of OC/site of oral lesions. Sixty-one participants attending the screening project for OC and OPMDs at the Northeastern district hospitals of Thailand were recruited. Information related to risk factors and biopsy tissues for histopathological diagnosis was collected. Sixty-seven paraffin tissue blocks, including 52 OPMDs and 15 OC specimens, were investigated for EBV infection, using PCR analysis with latent membrane protein-1 (LMP-1) primer and EBERs ISH. Pearson’s Chi-square or Fisher’s exact test was used to analyze the differences in variables between participants with OPMDs and OC, as appropriate. The association between EBV infection and related risk factors was analyzed using logistic regression with a significant level at 0.05. Using PCR analysis, 8 of 67 specimens (11.94%) were positive for LMP-1. Three cases of OPMDs were positive for both LMP-1 PCR and EBERs ISH. Regarding risk factors of OC, the two most common risk factors were betel nut chewing (52.46%) and working in sunlight (42.62%). The habit of taking alcohol was significantly different between the OC and the OPMDs groups (p = 0.009). The association between LMP-1 and the lesion at the tongue was statistically significant, with odds ratio = 4.900 (95% confidence interval = 1.046–22.943; p = 0.044). The prevalence of EBV infection in this group of participants was low. However, OPMDs at the tongue exhibited a significant association with EBV infection.

[1]  B. Klongnoi,et al.  Histopathological and risk factor analyses of oral potentially malignant disorders and oral cancer in a proactive screening in northeastern Thailand , 2022, BMC oral health.

[2]  Robert E. White,et al.  Do Epstein–Barr Virus Mutations and Natural Genome Sequence Variations Contribute to Disease? , 2021, Biomolecules.

[3]  C. Snapper,et al.  Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases , 2021, Frontiers in Immunology.

[4]  S. Woo,et al.  Oral hairy leukoplakia: a series of 45 cases in immunocompetent patients. , 2021, Oral surgery, oral medicine, oral pathology and oral radiology.

[5]  R. Marsault,et al.  Detection of Epstein–Barr Virus in Periodontitis: A Review of Methodological Approaches , 2020, Microorganisms.

[6]  T. Chen,et al.  Effect of metabolic syndrome on incidence of oral potentially malignant disorder: a prospective cohort study in Taiwan , 2020, BMJ Open.

[7]  Z. Herceg,et al.  Arguments to Support a Viral Origin of Oral Squamous Cell Carcinoma in Non-Smoker and Non-Drinker Patients , 2020, Frontiers in Oncology.

[8]  Sagheer Ahmed,et al.  Prevalence of EBV, CMV, and HPV in oral squamous cell carcinoma patients in the Pakistani population , 2020, Journal of medical virology.

[9]  S. Sangrajrang,et al.  National Cancer Control Program of Thailand , 2020, Asian Pacific journal of cancer prevention : APJCP.

[10]  S. Gan,et al.  Recent Advances in Diagnostic Approaches for Epstein–Barr Virus , 2020, Pathogens.

[11]  G. Weinstein,et al.  Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and meta‐analysis of malignant transformation rate by subtype , 2019, Head & neck.

[12]  S. Poomsawat,et al.  Overexpression of Epstein-Barr virus-encoded latent membrane protein-1 (LMP-1) in oral squamous cell carcinoma , 2019, BMC oral health.

[13]  N. Kitkumthorn,et al.  Distribution of the Epstein‐Barr virus in the normal stomach and gastric lesions in Thai population , 2018, Journal of medical virology.

[14]  A. Malki,et al.  Epstein–Barr Virus-Associated Malignancies: Roles of Viral Oncoproteins in Carcinogenesis , 2018, Front. Oncol..

[15]  S. Warnakulasuriya Clinical features and presentation of oral potentially malignant disorders. , 2018, Oral surgery, oral medicine, oral pathology and oral radiology.

[16]  J. Hansen,et al.  Cancer incidence among merchant seafarers: an extended follow-up of a Danish cohort , 2018, Occupational and Environmental Medicine.

[17]  N. Yazdani,et al.  Association between epstein barr virus and tongue squamous cell carcinoma in iranian patients. , 2017, Pathology, research and practice.

[18]  V. Mysorekar,et al.  Expression of Epstein–Barr virus among oral potentially malignant disorders and oral squamous cell carcinomas in the South Indian tobacco‐chewing population , 2017, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[19]  T. Nozaki,et al.  Detection of Epstein-Barr virus genome and latent infection gene expression in normal epithelia, epithelial dysplasia, and squamous cell carcinoma of the oral cavity , 2016, Tumor Biology.

[20]  G. Pimienta,et al.  Consideration of Epstein-Barr Virus-Encoded Noncoding RNAs EBER1 and EBER2 as a Functional Backup of Viral Oncoprotein Latent Membrane Protein 1 , 2016, mBio.

[21]  P. Vatanasapt,et al.  Association of Epstein-Barr virus infection with oral squamous cell carcinoma in a case-control study. , 2015, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[22]  X. Gu,et al.  Oral dysplasia and squamous cell carcinoma: correlation between increased expression of CD21, Epstein-Barr virus and CK19. , 2012, Oral oncology.

[23]  I. Chitapanarux,et al.  Analysis of 587 cases of oral squamous cell carcinoma in northern Thailand with a focus on young people. , 2004, International journal of oral and maxillofacial surgery.

[24]  A. Preeti,et al.  Incidence OF HPV and EBV in oral cancer and their clinico-pathological correlation- a pilot study of 108 cases. , 2021, Journal of oral biology and craniofacial research.

[25]  Amy Ming-Fang Yen,et al.  Prevalence and Factors Associated with Oral Pre-Malignant Lesions in Northeast Thailand. , 2016, Asian Pacific journal of cancer prevention : APJCP.

[26]  Jun Hu,et al.  Comparison of three methods for the detection of Epstein-Barr virus in Hodgkin's lymphoma in paraffin-embedded tissues. , 2013, Molecular medicine reports.